Advancing the Treatment of Immune and Inflammatory Diseases
Vial is developing innovative therapies for the treatment of Immunology and Inflammation diseases. Our goal is to bring forward best-in-class therapeutics that advance the standard of care.
Our approach combines advanced antibody engineering, immune pathway modulation, and next-generation biologics to directly target the mechanisms that fuel inflammatory disorders.
- Restore balance across dysregulated cytokine networks
- Reduce tissue damage driven by chronic immune activation
- Improve long-term outcomes across autoimmune and inflammatory diseases
- Unlock new therapeutic options for patients underserved by existing treatments
Our Pipeline
We’re developing best-in-class biologics for the treatment of immune-related and inflammation diseases.
Join the Future of Inflammatory Disease Treatment
Vial’s clinical research teams are working with investigators across multiple specialties to evaluate the next wave of immunology therapeutics. Individuals with immune-mediated inflammatory conditions may be eligible for early studies.
Contact
Get in touch
Build the future of drug development with us
"*" indicates required fields
